Authors: BRIGHTY KE GOOTZ TD

Citation: Ke. Brighty et Td. Gootz, THE CHEMISTRY AND BIOLOGICAL PROFILE OF TROVAFLOXACIN, Journal of antimicrobial chemotherapy, 39, 1997, pp. 1-14

Authors: BRIGHTY KE CASTALDI MJ

Citation: Ke. Brighty et Mj. Castaldi, SYNTHESIS OF -ALPHA,6-ALPHA)-6-AMINO-3-AZABICYCLO[3.1.0]HEXANE, A NOVEL ACHIRAL DIAMINE, Synlett, (11), 1996, pp. 1097

Authors: GOOTZ TD BRIGHTY KE

Citation: Td. Gootz et Ke. Brighty, FLUOROQUINOLONE ANTIBACTERIALS - SAR, MECHANISM OF ACTION, RESISTANCE, AND CLINICAL ASPECTS, Medicinal research reviews, 16(5), 1996, pp. 433-486

Authors: DALVIE DK KHOSLA NB NAVETTA KA BRIGHTY KE

Citation: Dk. Dalvie et al., METABOLISM AND EXCRETION OF TROVAFLOXACIN, A NEW QUINOLONE ANTIBIOTIC, IN SPRAGUE-DAWLEY RATS AND BEAGLE DOGS - EFFECT OF BILE-DUCT CANNULATION ON EXCRETION PATHWAYS, Drug metabolism and disposition, 24(11), 1996, pp. 1231-1240

Authors: REITER LA BRIGHTY KE BRYANT RA GOLDSMITH ME

Citation: La. Reiter et al., SYNTHESIS OF MONO N-SUBSTITUTED GUANYLTHIOUREAS, Synthetic communications, 26(7), 1996, pp. 1423-1429

Authors: GOOTZ TD BRIGHTY KE ANDERSON MR SCHMIEDER BJ HASKELL SL SUTCLIFFE JA CASTALDI MJ MCGUIRK PR

Citation: Td. Gootz et al., IN-VITRO ACTIVITY OF CP-99,219, A NOVEL 7-(3-AZABICYCLO[3.1.0]HEXYL) NAPHTHYRIDONE ANTIMICROBIAL, Diagnostic microbiology and infectious disease, 19(4), 1994, pp. 235-243